Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Heart Failure

  Free Subscription


01.04.2019

7 Eur J Heart Fail
1 Heart
8 Int J Cardiol
2 J Am Coll Cardiol
1 J Card Fail
2 J Cardiol
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Eur J Heart Fail

  1. CERISANO G, Buonamici P, Migliorini A, Santini A, et al
    Relation between post-myocardial infarct remodelling and gelatinase activity in patients enrolled in the TIPTOP trial.
    Eur J Heart Fail. 2019;21:127-129.
    PubMed     Text format    

  2. VAN KEER JM, Vanassche T, Droogne W, Rex S, et al
    Idarucizumab for the reversal of dabigatran in patients undergoing heart transplantation.
    Eur J Heart Fail. 2019;21:129-131.
    PubMed     Text format    

  3. WESSLER BS, McCauley M, Morine K, Konstam MA, et al
    Relation between therapy-induced changes in natriuretic peptide levels and long-term therapeutic effects on mortality in patients with heart failure and reduced ejection fraction.
    Eur J Heart Fail. 2019 Mar 27. doi: 10.1002/ejhf.1411.
    PubMed     Text format     Abstract available

  4. O'CONNOR C, Fiuzat M, Mulder H, Coles A, et al
    Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score.
    Eur J Heart Fail. 2019 Mar 27. doi: 10.1002/ejhf.1450.
    PubMed     Text format     Abstract available

  5. REDDY YNV, Obokata M, Egbe A, Yang JH, et al
    Left atrial strain and compliance in the diagnostic evaluation of heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2019 Mar 28. doi: 10.1002/ejhf.1464.
    PubMed     Text format     Abstract available

  6. FUSSNER LA, Karlstedt E, Hodge DO, Fine NM, et al
    Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres.
    Eur J Heart Fail. 2018;20:1713-1720.
    PubMed     Text format     Abstract available

  7. NAUTA JF, Jin X, Hummel YM, Voors AA, et al
    Markers of left ventricular systolic dysfunction when left ventricular ejection fraction is normal.
    Eur J Heart Fail. 2018;20:1636-1638.
    PubMed     Text format    


    Heart

  8. CHRISTIANSEN MN, Kober L, Torp-Pedersen C, Smith JG, et al
    Prevalence of heart failure and other risk factors among first-degree relatives of women with peripartum cardiomyopathy.
    Heart. 2019 Mar 25. pii: heartjnl-2018-314552. doi: 10.1136/heartjnl-2018-314552
    PubMed     Text format     Abstract available


    Int J Cardiol

  9. WILLIAMS MR
    The CARVIVA HF trial- Is the devil in the detail?
    Int J Cardiol. 2019;274:260.
    PubMed     Text format    

  10. GIANNONI A, Raglianti V, Taddei C, Borrelli C, et al
    Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure.
    Int J Cardiol. 2019 Mar 17. pii: S0167-5273(19)30986.
    PubMed     Text format     Abstract available

  11. AIMO A, Vergaro G, Cohen Solal A, Emdin M, et al
    Relative hypochromia in acute heart failure to predict outcome and guide treatment: Ready for prime time?
    Int J Cardiol. 2019 Mar 18. pii: S0167-5273(19)31127.
    PubMed     Text format    

  12. FOGARASSY G, Vathy-Fogarassy A, Kenessey I, Kasler M, et al
    Risk prediction model for long-term heart failure incidence after epirubicin chemotherapy for breast cancer - A real-world data-based, nationwide classification analysis.
    Int J Cardiol. 2019 Mar 15. pii: S0167-5273(18)35873.
    PubMed     Text format     Abstract available

  13. SHOAIB A, Mamas MA, Ahmad QS, McDonagh TM, et al
    Characteristics and outcome of acute heart failure patients according to the severity of peripheral oedema.
    Int J Cardiol. 2019 Mar 15. pii: S0167-5273(18)34755.
    PubMed     Text format     Abstract available

  14. OLIVOTTO I, Maurizi N
    Exercise testing in hypertrophic cardiomyopathy: A pathophysiological goldmine with protean clinical implications.
    Int J Cardiol. 2019;274:257-259.
    PubMed     Text format    

  15. SCHMEDERER Z, Rolim N, Bowen TS, Linke A, et al
    Endothelial function is disturbed in a hypertensive diabetic animal model of HFpEF: Moderate continuous vs. high intensity interval training.
    Int J Cardiol. 2018;273:147-154.
    PubMed     Text format     Abstract available

  16. RECCHIA FA, Gorgodze N, Gabisonia K
    Pathogenic role of mitochondrial calcium uniporter upregulation in the failing heart: Ca(2+) mishandling or what else?
    Int J Cardiol. 2019;274:250-251.
    PubMed     Text format    


    J Am Coll Cardiol

  17. TAYLOR RS, Walker S, Smart NA, Piepoli MF, et al
    Impact of Exercise Rehabilitation on Exercise Capacity and Quality-of-Life in Heart Failure: Individual Participant Meta-Analysis.
    J Am Coll Cardiol. 2019;73:1430-1443.
    PubMed     Text format     Abstract available

  18. LAVIE CJ, Ozemek C, Arena R
    Bringing Cardiac Rehabilitation and Exercise Training to a Higher Level in Heart Failure.
    J Am Coll Cardiol. 2019;73:1444-1446.
    PubMed     Text format    


    J Card Fail

  19. ADIE S, Bitar A, Hanigan S, Pogue K, et al
    Real-world prevalence of adverse events after initiating sacubitril/valsartan compared to angiotensin converting enzyme inhibitors or angiotensin receptor blockers in systolic heart failure.
    J Card Fail. 2019 Mar 20. pii: S1071-9164(18)31292.
    PubMed     Text format    


    J Cardiol

  20. GOLDSMITH SR
    Arginine vasopressin antagonism in heart failure: Current status and possible new directions.
    J Cardiol. 2019 Mar 20. pii: S0914-5087(19)30053.
    PubMed     Text format     Abstract available

  21. MACHINO-OHTSUKA T, Seo Y, Ishizu T, Yamamoto M, et al
    Relationships between maintenance of sinus rhythm and clinical outcomes in patients with heart failure with preserved ejection fraction and atrial fibrillation.
    J Cardiol. 2019 Mar 22. pii: S0914-5087(19)30057.
    PubMed     Text format     Abstract available


    PLoS One

  22. LU Q, Dong N, Wang Q, Yi W, et al
    Correction: Increased Levels of Plasma Soluble Sema4D in Patients with Heart Failure.
    PLoS One. 2019;14:e0214894.
    PubMed     Text format     Abstract available

  23. CHEN TY, Kao CW, Cheng SM, Chang YC, et al
    Correction: Uncertainty and depressive symptoms as mediators of quality of life in patients with heart failure.
    PLoS One. 2019;14:e0214825.
    PubMed     Text format     Abstract available

  24. SPINAR J, Spinarova L, Malek F, Ludka O, et al
    Prognostic value of NT-proBNP added to clinical parameters to predict two-year prognosis of chronic heart failure patients with mid-range and reduced ejection fraction - A report from FAR NHL prospective registry.
    PLoS One. 2019;14:e0214363.
    PubMed     Text format     Abstract available

  25. AMIN A, Garcia Reeves AB, Li X, Dhamane A, et al
    Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure.
    PLoS One. 2019;14:e0213614.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: